During the past decade, Genesis Cancer Center conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 15 clinical trials were completed, i.e. on average, 65.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Genesis Cancer Center" #1 sponsor was "Celgene" with 6 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Genentech, Inc." with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Exact Sciences Corporation" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Cancer Center" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "Bionomics Limited" with 1 trials as a collaborator, "CIRION Central Laboratory" with 1 trials as a collaborator and "Dorevitch" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Genesis Cancer Center" are "Breast Cancer" (6 trials), "Small Cell Lung Cancer" (5 trials), "Colorectal Cancer" (4 trials), "Non-Small Cell Lung Cancer" (4 trials) and "Melanoma" (3 trials). Many other conditions were trialed in "Genesis Cancer Center" in a lesser frequency.

Most popular intervention types in "Genesis Cancer Center" are "Drug" (39 trials), "Biological" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (5 trials), "Paclitaxel" (5 trials), "Placebo" (5 trials), "Docetaxel" (4 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Genesis Cancer Center" are 43 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Genesis Cancer Center". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Genesis Cancer Center, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Genesis Cancer Center, 5 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".